BCAN Scientific Advisory Board

BCAN’s Scientific Advisory Board (SAB) is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada. All have made outstanding contributions in their own fields and we are proud to have their involvement on our behalf.

The Board is currently chaired by Dr. Gary D. Steinberg, University of Chicago.  Prior SAB Chairpersons are indicated with an asterisk (*).

Gary D. Steinberg, MD, FACS, Chairperson
University of Chicago
Chicago, Illinois

Hikmat Al-Ahmadie, MD
Memorial Sloan-Kettering Cancer Center
New York, New York 

Andrea Apolo, MD    

National Cancer Institute, Bethesda, Maryland

Jessie Au, Pharm.D, PhD
Optimum Therapeutics
San Diego, California

Dean F. Bajorin, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Trinity J. Bivalacqua, MD, PhD
Johns Hopkins Medical Institutions
Baltimore, MD

Bernard Bochner, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Sam Chang, MD
Vanderbilt University School of Medicine
Nashville, Tennessee

Peter Clark, MD
Vanderbilt University School of Medicine
Nashville, Tennessee

Michael Cookson, MD
University of Oklahoma College of Medicine
Oklahoma City, Oklahoma

Guido Dalbagni, MD, FACS
Memorial Sloan-Kettering Cancer Center
New York, New York

Sia Daneshmand, MD
USC/Norris Comprehensive Cancer Center
Los Angeles, California

Rian J. Dickstein, M.D. 
Chesapeake Urology
Glen Burnie, MD

Colin P.N. Dinney, MD
MD Anderson Cancer Center
Houston, Texas

Robert Dreicer MD, MS, FACP, FASCO
University of Virginia Cancer Center
Charlottesville, Virginia

Michael Droller, MD
Mount Sinai Medical Center
New York, New York

Jason A. Efstathiou, M.D., D.Phil
Massachusetts General Hospital
Boston, Massachusetts

Mario L. Eisenberger, MD
Johns Hopkins Medical Institutions
Baltimore, Maryland

Bishoy M. Faltas, MD
Division of Hematology/Medical Oncology
Weill-Cornell Medical College

Matthew Galsky, MD
Mount Sinai School of Medicine
New York, New York

Scott M. Gilbert, MD, MS
Moffitt Cancer Center
Tampa, Florida

Mark L. Gonzalgo, MD, PhD
University of Miami
Miami, Florida

H. Barton Grossman, MD, FACS
MD Anderson Cancer Center
Houston, Texas

Noah M. Hahn, MD
Johns Hopkins Medical Institutions
Baltimore, Maryland

Jill Hamilton-Reeves, PhD, RD, CSO
University of Kansas Medical Center
Kansas City, Kansas

Donna Hansel, MD, PhD
UCSD, School of Medicine, La Jolla, California

Jean Hoffmann-Censtis, MD
Thomas Jefferson University Hospital
Philadelphia, PA

J. Stephen Jones, MD, FACS
Glickman Urological and Kidney Institute, Cleveland Clinic
Cleveland, Ohio

Ashish M. Kamat, MD
MD Anderson Cancer Center
Houston, Texas

Larry Karsh, MD, FACS, CPI
The Urology Center of Colorado
Denver, Colorado

Wassim Kassouf, MD
McGill University, Quebec, Canada

Badrinath Konety, MD, FACS, MBA
University of Minnesota
Minneapolis, Minnesota

Donald Lamm, MD, FACS
BCG Oncology
Phoenix, Arizona

David M. Latini, PhD
Baylor College of Medicine
Houston, Texas

Cheryl Lee, MD, FACS* 
The Ohio State University
Columbus, OH 

Seth Lerner, MD, FACS

Baylor College of Medicine
Houston, Texas

Yair Lotan, MD
UT Southwestern Medical Center
Dallas, Texas

Kevin Loughlin, MD, MBA, FACS
Brigham & Women’s Hospital
Boston, Massachusetts

S. Bruce Malkowicz, MD
University of Pennsylvania
Philadelphia, Pennsylvania

Ronac Mamtani, MD, MSCE
University of Pennsylvania
Philadelphia, Pennsylvania

David J. McConkey, PhD
Johns Hopkins Medical Institutions
Baltimore, MD

James McKiernan, MD
Columbia University
New York, New York

Maxwell Meng, MD
University of California, San Francisco
San Francisco, California

Edward M. Messing, MD, FACS
University of Rochester Medical Center
Rochester, New York

Matthew I. Milowsky, MD
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina

Matthew Nielsen, MD
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Michael O’Donnell, MD, FACS
Holden Cancer Center, University of Iowa Hospital, Iowa City, Iowa

Chong-xian Pan, MD, PhD
University of California Davis
Sacramento, California

Michael Porter, MD, MS
University of Washington
Seattle, Washington

Raj S. Pruthi, MD, FACS
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Steve Riggs, MD
Levine Cancer Institute
Charlotte, North Carolina

Jonathan E. Rosenberg, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Arthur I. Sagalowsky, MD
UT Southwestern Medical Center
Dallas, Texas

Mark Schoenberg, MD, FACS*
Albert Einstein College of Medicine
Bronx, NY

Shahrokh F. Shariat, MD
Medical University of Vienna
Vienna, Austria

William U. Shipley, MD, FACR
Harvard Medical School and Massachusetts General Hospital
Cambridge and Boston, Massachusetts

Neal D. Shore, MD, FACS
Carolina Urologic Research Center/Grand Strand Urology
Myrtle Beach, South Carolina

Eila Skinner, MD
Stanford University
Stanford, California

Norm D. Smith, MD
The University of Chicago
Chicago, Illinois

Mark Soloway, MD, FACS
Memorial Healthcare System
Aventura, Florida

Srikala Sridhar, MD
Princess Margaret Hospital
Toronto, Ontario

Walter Stadler, MD, FACP
University of Chicago
Chicago, Illinois

John A. Taylor, III, MD, MS
University of Kansas
Kansas City, Kansas

Dan Theodorescu, MD, PhD
University of Colorado Cancer Center
Denver, Colorado

Steven Wong, MD
UCLA Medical Center
Los Angeles, California

Share this page:Share on FacebookTweet about this on TwitterShare on Google+Share on TumblrShare on LinkedInEmail this to someone